Maravai Lifesciences Holdings (MAR) Stock Statistics & Valuation Metrics

Maravai Lifesciences Holdings has a market cap or net worth of EUR 1.82B. The enterprise value is EUR 1.18B.

Market Cap

EUR 1.82B

Enterprise Value

EUR 1.18B

Maravai Lifesciences Holdings has 148,989,550 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

148,989,550

Owned by Insiders

3.29%

Owned by Institutions

30.01%

Maravai Lifesciences Holdings’s return on equity (ROE) is -0.62 and return on invested capital (ROIC) is -0.91%.

Return on Equity (ROE)

-0.62

Return on Assets (ROA)

-0.17

Return on Invested Capital (ROIC)

-0.91%

Return on Capital Employed (ROCE)

-0.01

Revenue Per Employee

447.57K

Profits Per Employee

-315.12K

Employee Count

415

Asset Turnover

0.24

Inventory Turnover

3.76

The current PE Ratio of Maravai Lifesciences Holdings is -14.58. Maravai Lifesciences Holdings’s PEG ratio is -0.16.

PE Ratio

-14.58

PS Ratio

10.61

PB Ratio

5.65

Price to FCF

-63.10

Price to Operating Cash Flow

-45.76

PEG Ratio

-0.16

In the last 12 months, Maravai Lifesciences Holdings had revenue of 185.74M and earned -130.77M in profits. Earnings per share was -0.91.

Revenue

185.74M

Gross Profit

33.39M

Operating Income

-6.74M

Pretax Income

-234.97M

Net Income

-130.77M

EBITDA

-147.51M

Earnings Per Share (EPS)

-0.91

In the last 12 months, operating cash flow was -25.26M and capital expenditures -9.85M, giving a free cash flow of -35.11M billion.

Operating Cash Flow

-25.26M

Free Cash Flow

-35.11M

Free Cash Flow per Share

-0.24

Maravai Lifesciences Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-1.58%

Earnings Yield

-6.70%

Beta

0.64

52-Week Price Change

155.60%

50-Day Moving Average

6.51

200-Day Moving Average

4.50

Relative Strength Index (RSI)

53.27

Average Volume (3m)

420

Maravai Lifesciences Holdings upcoming earnings date is Nov 04, 2026, After Close (Not Confirmed).

Last Earnings Date

Aug 06, 2026

Next Earnings Date

Nov 04, 2026

Ex-Dividend Date

―

Maravai Lifesciences Holdings as a current ratio of 6.60, with Debt / Equity ratio of 16.75%

Current Ratio

6.60

Quick Ratio

5.69

Debt to Market Cap

0.04

Net Debt to EBITDA

1.23

Interest Coverage Ratio

-0.25

In the past 12 months, Maravai Lifesciences Holdings has paid -4.21M in taxes.

Income Tax

-4.21M

Effective Tax Rate

0.02

Maravai Lifesciences Holdings EV to EBITDA ratio is -41.78, with an EV/FCF ratio of -66.13.

EV to Sales

11.12

EV to EBITDA

-41.78

EV to Free Cash Flow

-66.13

EV to Operating Cash Flow

-91.91

Maravai Lifesciences Holdings has EUR 70.09M in cash and marketable securities with EUR 176.70M in debt, giving a net cash position of -EUR 106.61M billion.

Cash & Marketable Securities

EUR 70.09M

Total Debt

EUR 176.70M

Net Cash

-EUR 106.61M

Net Cash Per Share

-EUR 0.72

Tangible Book Value Per Share

EUR 0.59

Gross margin is 34.61%, with operating margin of 46.02%, and net profit margin of -37.07%.

Gross Margin

34.61%

Operating Margin

46.02%

Pretax Margin

-65.38%

Net Profit Margin

-37.07%

EBITDA Margin

-26.62%

EBIT Margin

-53.90%

The average price target for Maravai Lifesciences Holdings is EUR 7.02, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

EUR 7.02

Price Target Upside

2.45% Upside

Analyst Consensus

Moderate Buy

Analyst Count

6

Revenue Growth Forecast

-9.86%

EPS Growth Forecast

63.50%

Smart Score

9

AI Score

―